Alexion Pharmaceuticals, Inc.

Baird Financial Group, Inc. ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/11/2021

Shares

2,434

Value ($000)

447

Weight

0.0%

2019 Q4 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/11/2021	447	0.0%	2,434	6/30/2021
2021 Q1	5/13/2021	391	0.0%	2,554	3/31/2021
2020 Q4	2/11/2021	531	0.0%	3,399	12/31/2020
2020 Q3	11/12/2020	396	0.0%	3,461	9/30/2020
2020 Q2	10/22/2020	389	0.0%	3,466	6/30/2020
2020 Q1	5/14/2020	333	0.0%	3,707	3/31/2020
2019 Q4	2/14/2020	37,864	0.1%	350,105	12/31/2019